Mesenchymal stem cell (MSC)-based therapy has been considered as a promising
approach targeting a variety of intractable diseases due to remarkable multiple effect of …

Diabetic foot ulcers (DFUs) are the fastest growing chronic complication of diabetes mellitus,
with more than 400 million people diagnosed globally, and the condition is responsible for …

Background Mesenchymal stem cell (MSC)-based tissue engineering plays a major role in
regenerative medicine. However, the efficiency of MSC transplantation and survival of …

Cell-based therapies have the potential to revolutionize current treatments for diseases with
high prevalence and related economic and social burden. Unfortunately, clinical trials have …

In the physiological condition, the skeletal system's bone resorption and formation are in
dynamic balance, called bone homeostasis. However, bone homeostasis is destroyed under …

Cell-based therapy (CBT) is a revolutionary approach for curing a variety of degenerative
diseases. Stem cell-based regenerative medicine is a novel strategy for treating tissue …

Background Diabetic polyneuropathy (DPN) is the most common and early develo**
complication of diabetes mellitus, and the key contributor for foot ulcers development, with …

Recently published studies suggest that the paracrine substances released by
mesenchymal stem cells (MSCs) are the primary motive behind the therapeutic action …

Deferoxamine (DFO) has been in use for half a century as a Food and Drug Administration-
approved iron chelator, but recent studies indicate a variety of properties that could expand …

The potential use of stem cell-based therapies for the repair and regeneration of various
tissues and organs is a major goal in repair medicine. Stem cells are classified by their …